4D Molecular Therapeutics Inc. – Articles of Incorporation

NASDAQ: FDMT
Share price (11/9/26): $12.48
Market cap (11/9/26): $689 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Articles of Incorporation Filter

from 8-K 38 pages Amended and Restated Bylaws of 4D Molecular Therapeutics, Inc

from 8-K 36 pages Amended and Restated Bylaws of 4D Molecular Therapeutics, Inc

from 8-K 34 pages Amended and Restated Bylaws of 4D Molecular Therapeutics, Inc

from 8-K 33 pages Amended and Restated Bylaws of 4D Molecular Therapeutics, Inc

from 8-K 7 pages Amended and Restated Certificate of Incorporation of 4D Molecular Therapeutics, Inc

from S-1/A 33 pages Amended and Restated Bylaws of 4D Molecular Therapeutics, Inc

from S-1/A 7 pages Amended and Restated Certificate of Incorporation of 4D Molecular Therapeutics, Inc

from S-1 25 pages Bylaws of 4D Molecular Therapeutics, Inc. Adopted March 20, 2015

from S-1 30 pages Fourth Amended and Restated Certificate of Incorporation of 4D Molecular Therapeutics, Inc

from S-1 25 pages Bylaws of 4D Molecular Therapeutics, Inc. Adopted March 20, 2015

from S-1 27 pages Third Amended and Restated Certificate of Incorporation of 4D Molecular Therapeutics, Inc

from DRS 25 pages Bylaws of 4D Molecular Therapeutics, Inc. Adopted March 20, 2015

from DRS 27 pages Third Amended and Restated Certificate of Incorporation of 4D Molecular Therapeutics, Inc